Adverse effects of different types of medication can cause various patterns of colitis.(1) The immunosuppresive drugs Mycophenolic acid and anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) antibody Ipilimumab are known to cause a graft-versus-host disease (GVHD)-like apoptotic enteropathy (AE).(1,2) Recently, antimetabolites (Methotrexate and Capecitabine) and tumour necrosis factor-α (TNF-α) inhibitors (Etanercept and Infliximab) have also been reported to cause similar changes.(2) Adalimumab is a fully humanized anti TNF-α monoclonal antibody that has been approved by the Food and Drug Administration (FDA) for use in Crohn's disease and ulcerative colitis (UC).(3,4) Here we present a case of apoptic enteropathy (AE) in a patient with ulcerative colitis, who was being treated with Adalimumab. To best of our knowledge, this is the first such case reported in the literature. This article is protected by copyright. All rights reserved.
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2016.
All research outputs
#7,425,202
of 28,431,481 outputs
Outputs from Colorectal Disease
#1,598
of 3,633 outputs
Outputs of similar age
#88,865
of 317,679 outputs
Outputs of similar age from Colorectal Disease
#14
of 33 outputs
Altmetric has tracked 28,431,481 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,633 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,679 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
